What's more, the FDA doesn't recommend Paxlovid for people who have severe liver and kidney disease.
The Merck drug hasn't even been approved because the experts are worried about potential side effects. Because of this, the FDA has restricted its use to adults, and only in scenarios in which other authorized treatments, including monoclonal antibodies produced by Regeneron and others, are inaccessible or are not "clinically appropriate."
===
Merck's Molnupiravir is a known mutagen.
"β-d-N4-hydroxycytidine Inhibits SARSCoV- 2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells"
The Journal of Infectious Diseases® 2021;224:415–9
Least we kid ourselves the willing participants will line up like they have for two years strait.
No comments:
Post a Comment